Association of a 0.85 Ratio of Endoscope-Sheath Diameter Threshold with Infectious Complications after Retrograde

Han Kyu Chae1, Dongrul Shin2, Hyun Cheol Jeong1

  • 1Department of Urology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.

Abstract

Insights

A higher ratio of endoscope-sheath diameter (RESD) greater than 0.85 is linked to increased infectious complications after retrograde intrarenal surgery (RIRS). This RESD threshold offers better risk assessment than the standard <0.75 target.

Area of Science:

  • Urology
  • Surgical Innovation
  • Infectious Disease

Background:

  • Postoperative infectious complications are a concern after retrograde intrarenal surgery (RIRS).
  • The ratio of endoscope-sheath diameter (RESD) is a potential factor influencing these complications.
  • Current practice often uses a RESD target of <0.75.

Purpose of the Study:

  • To evaluate the clinical impact of RESD on infectious complications following RIRS.
  • To compare the risk discrimination of a RESD threshold of 0.85 versus the conventional target of <0.75.

Main Methods:

  • Retrospective analysis of 243 adult patients undergoing RIRS at two academic institutions.
  • RESD calculated as ureteroscope outer diameter divided by ureteral access sheath inner diameter.
  • Infection rates analyzed across RESD categories (<0.75, 0.75-<0.85, >0.85) and dichotomous thresholds (0.75, 0.85) using logistic regression.

Main Results:

  • Infection rates increased with higher RESD categories (2.6% for <0.75, 4.6% for 0.75-<0.85, 14.6% for >0.85; p=0.009).
  • RESD >0.85 was significantly associated with higher infection rates (14.6% vs 4.1%; p=0.007), unlike the 0.75 threshold (p=0.214).
  • RESD >0.85 (aOR 3.73) and positive stone culture (aOR 3.50) were independent predictors of infectious complications.

Conclusions:

  • An RESD greater than 0.85 is independently associated with increased infectious complications after RIRS.
  • The RESD threshold of 0.85 provides superior risk stratification compared to the <0.75 target.
  • Assessing for infected stones is crucial in managing post-RIRS infectious risk.